Cambria Investment Management, L.P. United Therapeutics Corp Transaction History
Cambria Investment Management, L.P.
- $1.4 Billion
- Q2 2025
A detailed history of Cambria Investment Management, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cambria Investment Management, L.P. holds 2,197 shares of UTHR stock, worth $950,619. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,197
Previous 2,236
1.74%
Holding current value
$950,619
Previous $689,000
8.42%
% of portfolio
0.04%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding UTHR
# of Institutions
747Shares Held
43.9MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.37 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.92 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.03 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$938 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$917 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $19.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...